Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer

NCT00321685 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

NIH

Sponsor class

Conditions

Rectal Adenocarcinoma
Stage II Rectal Cancer AJCC v7
Stage III Rectal Cancer AJCC v7

Interventions

BIOLOGICAL: Bevacizumab
DRUG: Capecitabine
DRUG: Fluorouracil
DRUG: Leucovorin Calcium
DRUG: Oxaliplatin
RADIATION: Radiation Therapy
PROCEDURE: Therapeutic Conventional Surgery

Sponsor

National Cancer Institute (NCI)